JAN 12, 2022 6:01 PM PST

Should You Intentionally Get Omicron?

WRITTEN BY: Alexandria Bass

With the pandemic coming up on its 2-year anniversary, the ironic question more people are contemplating with this less deadly version of the virus is - "Should I intentionally get Omicron?” Since it's likely not going to just vanish out of existence, people are ready for COVID to be endemic, where it's seasonal, infects fewer people at a time and hopefully is milder in severity on average. But to get there takes multiple waves and reinfections so that more people gain immunity and so that immunity can last between seasonal outbreaks.

So, with COVID on its way to endemicity and all of us along for the ride, the vaccinated and unvaccinated alike have begun to wonder if infection with this highly contagious -but milder omicron variant- can help get us there sooner and give us some protection against future variants that could be worse.

Despite 62.6% of Americans being fully vaccinated and 3 previous COVID waves, a record-breaking nearly 1.4 million new COVID cases were reported to the CDC in a single day this week. 

BioNTech's CEO, Ugur Sahin, has commented that even people who are triple-vaccinated can transmit COVID and that the vaccine is now 70 to 75% effective against Omicron, down from the 95% effectiveness achieved against the original strain. 

Natural infection with SARS-CoV-2 is also thought to provide better defenses to the mucous membranes in the nose and throat, the virus's natural point of entry, that vaccination in the arm muscle can't, along with better knowledge for combating the virus since it recognizes other components than the spike protein alone targeted by vaccines. 

It's clear that mother nature has a mind of her own. And, unfortunately, that's the same caveat with natural infection, that nature is never entirely predictable, and despite being a milder version and vaccines said to decrease symptom severity on average, nothing is guaranteed. Everyone responds differently to a virus, so what is mild to one person may be catastrophic to another, even if the odds are against severe disease. Long COVID is also a potential risk for anyone who's been infected, regardless of their vaccination status. 

Plus, no one is sure how well immunity from Omicron will protect against future strains. Some people who get infected with Omicron may only have a modest bump in protection.

Take home message: take precautions, be sanitary, isolate when sick or after a known exposure and do not intentionally get sick if you can help it. The immune system's response to an infection can be a gamble, even with milder viruses.

Sources: The Atlantic, Time, Deseret News

About the Author
  • Alexandria (Alex) is a freelance science writer with a passion for educating the public on health issues. Her other professional experience includes working as a speech-language pathologist in health care, a research assistant in a food science laboratory, and an English teaching assistant in Spain. In her spare time, Alex enjoys cycling, lap swimming, jogging, and reading.
You May Also Like
DEC 22, 2021
Technology
E-waste Recycling Processes Emit Synthetic Antioxidants With Possible Health Risks
DEC 22, 2021
E-waste Recycling Processes Emit Synthetic Antioxidants With Possible Health Risks
Electronic waste (e-waste) refers to electronic material that has reached the end of its life and is ready to be recycle ...
DEC 27, 2021
Microbiology
Anthrax Toxin Has Potential as Non-Opioid Pain Therapeutic
DEC 27, 2021
Anthrax Toxin Has Potential as Non-Opioid Pain Therapeutic
Anthrax conjures thoughts of bioterrorism, though it's a disease caused by a rare but naturally-occurring bacterium, Bac ...
JAN 05, 2022
Clinical & Molecular DX
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
JAN 05, 2022
Labroots 2021 Clinical Research & Diagnostics Virtual Event's Winning Poster
The SARS-CoV-2 virus that emerged in December 2019 causes the disease COVID-19, a pandemic that has killed over 5 millio ...
JAN 07, 2022
Drug Discovery & Development
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
JAN 07, 2022
The genetic testing company 23andMe begins phase 1 clinical trial for cancer drug
This week, 23andMe, the consumer genetic testing giant, announced that it has begun a phase 1 clinical trial o ...
JAN 13, 2022
Cardiology
Extreme Exercise and Heart Disease Risk
JAN 13, 2022
Extreme Exercise and Heart Disease Risk
Marathons and HIIT workouts are more popular than ever. But how do they impact the heart?
JAN 18, 2022
Immunology
Humanized Mice Reveal the Origins of Lung Immune Cells
JAN 18, 2022
Humanized Mice Reveal the Origins of Lung Immune Cells
Viruses such as coronaviruses can be transmitted when an infected person coughs, sneezes, or talks. Cells called macroph ...
Loading Comments...